This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of March 2022. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
We do not have any donee information for the donee Sherlock Biosciences in our system.
|Cause area||Count||Median||Mean||Minimum||10th percentile||20th percentile||30th percentile||40th percentile||50th percentile||60th percentile||70th percentile||80th percentile||90th percentile||Maximum|
|Open Philanthropy (filter this donee)||17,500,000.00||17,500,000.00|
|Title (URL linked)||Publication date||Author||Publisher||Affected donors||Affected donees||Document scope||Cause area||Notes|
|How Philanthropists are Tackling COVID-19||2020-03-18||Abby Schultz||Barron's||Open Philanthropy Bill and Melinda Gates Foundation Wellcome Trust Mastercard Impact Fund Schmidt Futures||COVID-19 Therapeutics Accelerator Sherlock Biosciences Johns Hopkins Center for Health Security University of Washington (Institute for Protein Design)||Review of current state of cause area||Biosecurity and pandemic preparedness||The article describes how private philanthropy is helping in the fight against COVID-19 and the coronavirus pandemic caused by it. The role of Open Philanthropy Project in funding Sherlock Biosciences as well as the Johns Hopkins Center for Health Security in prior years is described. The article also describes the joint financing of the COVID-19 Therapeutics Accelerator by the Gates Foundation, Wellcome Trust, and Mastercard Impact Fund.|
|Explaining Our Bet on Sherlock Biosciences’ Innovations in Viral Diagnostics||2019-06-10||Heather Youngs Chris Somerville||Open Philanthropy||Open Philanthropy||Sherlock Biosciences||Single donation documentation||Scientific research||In this new-style blog post, the reasons for the Open Philanthropy Project grant https://www.openphilanthropy.org/focus/scientific-research/miscellaneous/sherlock-biosciences-research-viral-diagnostics to Sherlock Biosciences are explained in a conversational style. The conversation participants include Michael Levine (Communications Officer) and the grant investigators Chris Somerville and Heather Youngs.|
|With Launch Of New CRISPR Company, Competition Extends To Diagnostics||2019-03-21||Ellie Kincaid||Forbes||Open Philanthropy||Sherlock Biosciences||Launch||Scientific research||The article describes the launch of Sherlock Biosciences, a company that aims to use CRISPR technology for diagnostics. It mentions the $17.5 million donation https://www.openphilanthropy.org/focus/scientific-research/miscellaneous/sherlock-biosciences-research-viral-diagnostics plus undisclosed investment from the Open Philanthropy Project, as well as separate investment. Together, Sherlock Biosciences has raised $35 million.|
Graph of top 10 donors by amount, showing the timeframe of donations
|Donor||Amount (current USD)||Amount rank (out of 1)||Donation date||Cause area||URL||Influencer||Notes|
|Open Philanthropy||17,500,000.00||1||Scientific research/Biosecurity and pandemic preparedness||https://www.openphilanthropy.org/focus/scientific-research/miscellaneous/sherlock-biosciences-research-viral-diagnostics||Chris Somerville Heather Youngs||Donation process: The Open Philanthropy Project's scientific advisors Chris Somerville and Heather Youngs were hopeful about viral diagnostics after hearing of research coming out of Feng Zhang's lab (Zhang would later co-found Sherlock Biosciences). When they ran into David Walt, they asked him if his new company (Sherlock Biosciences) would be interested in developing a viral diagnostic, and after consulting with his team, he said they would. This started the process of vetting Sherlock Biosciences for the grant
Intended use of funds (category): Direct project expenses
Intended use of funds: Grant to support the development of a diagnostic platform to identify any virus present in a patient sample.
Donor reason for selecting the donee: Chris Somerville and Heather Youngs have been interested in viral diagnostics because development of this technology could both reduce threats from viral pandemics and also benefit health care broadly. The selection of Sherlock Biosciences was because of their team and technology, which made it plausible that they could develop this technology
Other notes: The Open Philanthropy Project also recommended an additional investment in Sherlock Biosciences. Sherlock recently spun out of Harvard University’s Wyss Institute and the Broad Institute of MIT and Harvard. The launch of Sherlock Biosciences, and the funding by the Open Philanthropy Project, are discussed in Forbes at https://www.forbes.com/sites/elliekincaid/2019/03/21/with-launch-of-new-crispr-company-competition-extends-to-diagnostics/ More background explanation related to the grant is in the conversation blog post https://www.openphilanthropy.org/blog/explaining-our-bet-sherlock-biosciences-innovations-viral-diagnostics. Intended funding timeframe in months: 60; announced: 2019-03-21.